The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice

Microbial Pathogenesis

Volumn 41, Issue 2-3, 2006, Pages 111-118

  Sashinami, Hiroshi ^a   Sakuraba, Hirotake ^a   Ishiguro, Yoh ^a   Munakata, Akihiro ^a   Nishihira, Jun ^b   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cortisol; Innate immunity; Interleukin 10; Listeria monocytogenes; MIF

Indexed keywords

CYTOKINE ANTIBODY; HYDROCORTISONE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HYDROCORTISONE BLOOD LEVEL; LISTERIA MONOCYTOGENES; LISTERIOSIS; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN;

ANIMALS; ANTIBODIES, BACTERIAL; HYDROCORTISONE; IMMUNOGLOBULIN G; INTERLEUKIN-10; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL;

BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES;

EID: 33747113933     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2006.06.001     Document Type: Article

References (54)

1. de Jong Y.P., Abadia-Molina A.C., Satoskar A.R., Clarke K., Rietdijk S.T., Faubion W.A., et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2 (2001) 1061-1066
2. Leech M., Metz C., Bucala R., and Morand E.F. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum 43 (2000) 827-833
3. Bloom B.R., and Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 (1966) 80-82
4. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56 (1966) 72-77
5. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365 (1993) 756-759
6. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377 (1995) 68-71
7. Bozza M., Satoskar A.R., Lin G., Lu B., Humbles A.A., Gerard C., et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189 (1999) 341-346
8. Calandra T., Echtenacher B., Roy D.L., Pugin J., Metz C.N., Hultner L., et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 6 (2000) 164-170
9. Ohkawara T., Nishihira J., Takeda H., Hige S., Kato M., Sugiyama T., et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123 (2002) 256-270
10. Sakai Y., Masamune A., Satoh A., Nishihira J., Yamagiwa T., and Shimosegawa T. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 124 (2003) 725-736
11. Martiney J.A., Sherry B., Metz C.N., Espinoza M., Ferrer A.S., Calandra T., et al. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun 68 (2000) 2259-2267
12. Koebernick H., Grode L., David J.R., Rohde W., Rolph M.S., Mittrucker H.W., et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc Natl Acad Sci USA 99 (2002) 13681-13686
13. Satoskar A.R., Bozza M., Rodriguez Sosa M., Lin G., and David J.R. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 69 (2001) 906-911
14. Rodriguez-Sosa M., Rosas L.E., David J.R., Bojalil R., Satoskar A.R., and Terrazas L.I. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun 71 (2003) 1247-1254
15. Buchmeier N.A., and Schreiber R.D. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 82 (1985) 7404-7408
16. Havell E.A. Production of tumor necrosis factor during murine listeriosis. J Immunol 139 (1987) 4225-4231
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993) 547-549
18. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., et al. Immune response in mice that lack the interferon-γ receptor. Science 259 (1993) 1742-1745
19. Nakane A., Minagawa T., and Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 56 (1988) 2563-2569
20. Neighbors M., Xu X., Barrat F.J., Ruuls S.R., Churakova T., Debets R., et al. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon γ production. J Exp Med 194 (2001) 343-354
21. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
22. Rothe J., Lesslauer W., Lotscher H., Lang Y., Koebel P., Kontgen F., et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364 (1993) 798-802
23. Kurihara T., Warr G., Loy J., and Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186 (1997) 1757-1762
24. Czuprynski C.J., Brown J.F., Maroushek N., Wagner R.D., and Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 152 (1994) 1836-1846
25. Haak-Frendscho M., Brown J.F., Iizawa Y., Wagner R.D., and Czuprynski C.J. Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection. J Immunol 148 (1992) 3978-3985
26. Nakane A., Nishikawa S., Sasaki S., Miura T., Asano M., Kohanawa M., et al. Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in gamma interferon-depleted mice. Infect Immun 64 (1996) 1252-1258
27. + cells are early IFN-γ producers but impair resistance to Listeria monocytogenes infection. J Immunol 152 (1994) 1873-1882
28. Dai W.J., Kohler G., and Brombacher F. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol 158 (1997) 2259-2267
29. Frei K., Nadal D., Pfister H.W., and Fontana A. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med 178 (1993) 1255-1261
30. Kelly J.P., and Bancroft G.J. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol 26 (1996) 356-364
31. Wagner R.D., Maroushek N.M., Brown J.F., and Czuprynski C.J. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect Immun 62 (1994) 2345-2353
32. Deckert M., Soltek S., Geginat G., Lutjen S., Montesinos-Rongen M., Hof H., et al. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect Immun 69 (2001) 4561-4571
33. Samsom J.N., Annema A., Geertsma M.F., Langermans J.A., Groeneveld P.H., de Heer E., et al. Interleukin-10 has different effects on proliferation of Listeria monocytogenes in livers and spleens of mice. Infect Immun 68 (2000) 4666-4672
34. Lionakis M.S., and Kontoyiannis D.P. Glucocorticoids and invasive fungal infections. Lancet 362 (2003) 1828-1838
35. Dandona P., Aljada A., Ghanim H., Mohanty P., Hamouda W., and Al-Haddad W. Acute suppressive effect of hydrocortisone on p47 subunit of nicotinamide adenine dinucleotide phosphate oxidase. Metabolism 50 (2001) 548-552
36. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269 (1994) 13289-13295
37. Ohtsuka T., Kubota A., Hirano T., Watanabe K., Yoshida H., Tsurufuji M., et al. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation. J Biol Chem 271 (1996) 1651-1659
38. Ray A., and Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91 (1994) 752-756
39. Ray K.P., Farrow S., Daly M., Talabot F., and Searle N. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem J 328 Part 2 (1997) 707-715
40. Shimoyama M., Shimmura S., Tsubota K., and Oguchi Y. Suppression of nuclear factor κB and CD18-mediated leukocyte adhesion to the corneal endothelium by dexamethasone. Invest Ophthalmol Vis Sci 38 (1997) 2427-2431
41. Almawi W.Y., Melemedjian O.K., and Rieder M.J. An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant 13 (1999) 365-374
42. Kovalovsky D., Refojo D., Holsboer F., and Arzt E. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J Neuroimmunol 109 (2000) 23-29
43. Nakane A., Okamoto M., Asano M., Kohanawa M., Satoh Y., and Minagawa T. Protection by dexamethasone from a lethal infection with Listeria monocytogenes in mice. FEMS Immunol Med Microbiol 9 (1994) 163-170
44. Gerard C., Bruyns C., Marchant A., Abramowicz D., Vandenabeele P., Delvaux A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177 (1993) 547-550
45. Howard M., Muchamuel T., Andrade S., and Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177 (1993) 1205-1208
46. Balow J.E., Hurley D.L., and Fauci A.S. Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs. chronic administration on cell-mediated immunity. J Immunol 114 (1975) 1072-1076
47. Boss B., Neeck G., Engelhardt B., and Riedel W. Influence of corticosteroids on neutrophils, lymphocytes, their subsets, and T-cell activity markers in patients with active rheumatoid arthritis, compared to healthy controls. Ann N Y Acad Sci 876 (1999) 198-200
48. Duong M., Ouellet N., Simard M., Bergeron Y., Olivier M., and Bergeron M.G. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 178 (1998) 1472-1482
49. Langhoff E., Olgaard K., and Ladefoged J. The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures. Int J Immunopharmacol 9 (1987) 469-473
50. Nishihira J., Kuriyama T., Nishino H., Ishibashi T., Sakai M., and Nishi S. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure. Biochem Mol Biol Int 31 (1993) 841-850
51. Mitchell R., Bacher M., Bernhagen J., Pushkarskaya T., Seldin M.F., and Bucala R. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154 (1995) 3863-3870
52. Sakai M., Nishihira J., Hibiya Y., Koyama Y., and Nishi S. Glutathione binding rat liver 13 k protein is the homologue of the macrophage migration inhibitory factor. Biochem Mol Biol Int 33 (1994) 439-446
53. Nakane A., Yamada K., Hasegawa S., Mizuki D., Mizuki M., Sasaki S., et al. Endogenous cytokines during a lethal infection with Listeria monocytogenes in mice. FEMS Microbiol Lett 175 (1999) 133-142
54. Miura T., Kudo T., Matsuki A., Sekikawa K., Tagawa Y., Iwakura Y., et al. Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection. Infect Immun 69 (2001) 7234-7241